F30 CA275317/CA/NCI NIH HHS/United States[Grants and Funding] - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Year	Number of Results
2023	1
2024	2

Page 1

Preclinical evaluation and first-in-dog clinical trials of PBMC-expanded natural killer cells for adoptive immunotherapy in dogs with cancer.

Razmara AM, Farley LE, Harris RM, Judge SJ, Lammers M, Iranpur KR, Johnson EG, Dunai C, Murphy WJ, Brown CT, Rebhun RB, Kent MS, Canter RJ. Razmara AM, et al. J Immunother Cancer. 2024 Apr 16;12(4):e007963. doi: 10.1136/jitc-2023-007963. J Immunother Cancer. 2024. PMID: 38631708 Free PMC article.

Improved characterization and translation of NK cells for canine immunotherapy.

Razmara AM, Gingrich AA, Toedebusch CM, Rebhun RB, Murphy WJ, Kent MS, Canter RJ. Razmara AM, et al. Front Vet Sci. 2024 Feb 6;11:1336158. doi: 10.3389/fvets.2024.1336158. eCollection 2024. Front Vet Sci. 2024. PMID: 38379924 Free PMC article. Review.

Missing a "Missing Self" Mechanism: Modeling and Detection of Ly49 Expression in Canine NK Cells.

Gingrich AA, Razmara AM, Gingrich PW, Rebhun RB, Murphy WJ, Kent MS, Brown CT, Siegel JB, Canter RJ. Gingrich AA, et al. Immunohorizons. 2023 Nov 1;7(11):760-770. doi: 10.4049/immunohorizons.2300092. Immunohorizons. 2023. PMID: 37971282 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3 results

Results by year